Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

126 results about "DBm" patented technology

DBm (sometimes dBmW or decibel-milliwatts) is unit of level used to indicate that a power ratio is expressed in decibels (dB) with reference to one milliwatt (mW). It is used in radio, microwave and fiber-optical communication networks as a convenient measure of absolute power because of its capability to express both very large and very small values in a short form compared to dBW, which is referenced to one watt (1,000 mW).

Bone matrix compositions and methods

The present invention provides methods of improving the osteogenic and/or chondrogenic activity of a bone matrix, e.g., a dermineralized bone matrix (DBM), by exposing the bone matrix to one or more treatments or conditions. In preferred embodiments the bone matrix is derived from human bone. The treatment or condition may alter the structure of the bone matrix and/or cleave one or more specific proteins. Cleavage may generate peptides or protein fragments that have osteoinductive, osteogenic, or chondrogenic activity. Preferred treatments include collagenase and various other proteases. The invention further provides improved bone and cartilage matrix compositions that have been prepared according to the inventive methods and methods of treatment using the compositions. The invention further provides methods of preparing, testing, and using the improved bone matrix compositions. Ona assay comprises exposing relatively undifferentiated mesenchymal cells to a bone matrix composition and measuring expression of a marker characteristic of osteoblast or chondrocyte lineage(s). Increased expression of the marker relative to the level of the marker in cells that have been exposed to a control matrix (e.g., an inactivated or untreated matrix) indicates that the treatment or condition increased the osteogenic and/or chondrogenic activity of the bone matrix. Suitable cells include C2C12 cells. A suitable marker is alkaline phosphatase. The inventive methods increase the osteogenic and/or chondrogenic activity of human DBM when tested using this assay system.
Owner:WARSAW ORTHOPEDIC INC

Bone matrix compositions and methods

The present invention provides methods of improving the osteogenic and / or chondrogenic activity of a bone matrix, e.g., a dermineralized bone matrix (DBM), by exposing the bone matrix to one or more treatments or conditions. In preferred embodiments the bone matrix is derived from human bone. The treatment or condition may alter the structure of the bone matrix and / or cleave one or more specific proteins. Cleavage may generate peptides or protein fragments that have osteoinductive, osteogenic, or chondrogenic activity. Preferred treatments include collagenase and various other proteases. The invention further provides improved bone and cartilage matrix compositions that have been prepared according to the inventive methods and methods of treatment using the compositions. The invention further provides methods of preparing, testing, and using the improved bone matrix compositions. On a assay comprises exposing relatively undifferentiated mesenchymal cells to a bone matrix composition and measuring expression of a marker characteristic of osteoblast or chondrocyte lineage(s). Increased expression of the marker relative to the level of the marker in cells that have been exposed to a control matrix (e.g., an inactivated or untreated matrix) indicates that the treatment or condition increased the osteogenic and / or chondrogenic activity of the bone matrix. Suitable cells include C2C12 cells. A suitable marker is alkaline phosphatase. The inventive methods increase the osteogenic and / or chondrogenic activity of human DBM when tested using this assay system.
Owner:WARSAW ORTHOPEDIC INC

Passive optical network optical power meter calibration device and calibration method

The invention relates to a passive optical network optical power meter calibration device and a calibration method. The calibration device comprises three light sources, an adjustable optical attenuator, a standard optical power meter, a standard passive optical network power meter, an optical network unit and an optical line terminal. The three light sources are used for outputting continuous data flow optical power. Maximum output optical power of the wavelength of 1310 nanometers is no less than 0 decibel above 1 milliwatt (dBm). The output optical power of the wavelength of 1490 nanometers is no less than 0 dBm. Maximum output power of the wavelength of 1550 nanometers is no less than 20 dBm. When the continuous data flow optical power of the passive optical network optical power meter is calibrated, the adjustable optical attenuator is connected with the light sources. When bursting data flow optical power of the passive optical network optical power meter is calibrated, the adjustable optical attenuator is connected with the optical network unit of a passive optical network. The standard optical power meter is used for calibrating the continuous data flow optical power of the passive optical network optical power meter. The standard optical power meter is capable of being connected with the adjustable optical attenuator. The optical network unit and the optical line terminal are used for calibrating the bursting data flow optical power of the passive optical network optical power meter.
Owner:SHANGHAI INST OF MEASUREMENT & TESTING TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products